Panel: Going Public in 2026: The New Biotech Playbook
Wed, May 13
|
02:10 PM - 02:50 PM
Session details:
- How biotech companies are navigating today’s IPO market
- The rise of reverse mergers and SPACs as alternative routes to access public capital
- What investors are looking for today—from valuation expectations to stage of entry
- How capital is being recycled across the ecosystem and what that means for emerging biotech companies
- Real-world insights on structuring deals and choosing the right path to go public in a shifting market
